Phathom Pharmaceuticals Statistics
NASDAQ: PHATHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.66-0.42 (-8.27%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Phathom Pharmaceuticals by the numbers
Phathom Pharmaceuticals has a market capitalization of $378.8 million based on 81.29M shares outstanding. With trailing EPS of $-1.01, Phathom Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.5% below its 50-day average and 52.6% below its 200-day average.
Average daily trading volume is 1.45M shares, or about $6.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PHAT valuation vs. peer median
| Metric | PHAT | Peer median | Difference |
|---|---|---|---|
| Market cap | $378.82M | $375.06M | +1% |
| Avg. volume | 1.45M | 1.29M | +13% |
Peer median across 8 companies: IRD, AVTX, PBYI, OCS, ASPE, PEPG, OVID, CTNM.
Valuation
- Market cap
- $378.82M
- Forward P/E
- 5.18
- Price / sales (latest FY)
- 2.16
- EPS (TTM)
- $-1.01
- Shares outstanding
- 81.29M
Price and trading
- Previous close
- 5.08
- Open
- 5.03
- Day range
- 4.62 – 5.15
- 52-week range
- 4.62 – 18.31
- 52-week change
- -68.93%
- Beta
- —
- Volume
- 1.33M
- Average volume
- 1.45M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 378.82M
- Forward Pe
- 5.18
- Eps
- -1.01
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 18.31
- Week52 Low
- 4.62
- Avg Volume
- 1.45M
- Shares Outstanding
- 81.29M
- Ma50
- 6.61
- Ma200
- 9.82
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -74.55%
- Pct From52w Low
- 0.98%